Cargando…
Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents
BACKGROUND: The devastating impact of the SARS-CoV-2 pandemic prompted the development and emergency use authorization of two mRNA vaccines in early 2020. Vaccine trials excluded nursing home (NH) residents, limiting adverse event data that directly apply to this population. METHODS: To prospectivel...
Autores principales: | Bardenheier, Barbara H., Gravenstein, Stefan, Blackman, Carolyn, Gutman, Roee, Sarkar, Indra Neil, Feifer, Richard A., White, Elizabeth M., McConeghy, Kevin, Nanda, Aman, Mor, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162901/ https://www.ncbi.nlm.nih.gov/pubmed/34092431 http://dx.doi.org/10.1016/j.vaccine.2021.05.088 |
Ejemplares similares
-
Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection
por: Bardenheier, Barbara H., et al.
Publicado: (2021) -
No Increase in Short-Term Mortality Following COVID-19 Vaccination Among Nursing Home Residents
por: Bardenheier, Barbara, et al.
Publicado: (2021) -
Infections, Hospitalizations, and Deaths Among US Nursing Home Residents With vs Without a SARS-CoV-2 Vaccine Booster
por: McConeghy, Kevin W., et al.
Publicado: (2022) -
Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents
por: White, Elizabeth M., et al.
Publicado: (2021) -
Temperature in Nursing Home Residents Systematically Tested for SARS-CoV-2
por: Rudolph, James L., et al.
Publicado: (2020)